Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number Sort ascending | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| PAR-22-098 | December 10, 2024 | R21 | Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
| PAR-22-097 | December 10, 2024 | R01 | Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) |
| PAR-22-060 | January 8, 2025 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
| PAR-21-357 | January 8, 2025 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
| PAR-21-355 | November 17, 2024 | R21 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
| PAR-21-354 | November 17, 2024 | R03 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) |
| PAR-21-353 | November 6, 2024 | R01 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
| PAR-21-350 | June 22, 2024 | R01 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) |
| PAR-21-349 | June 22, 2024 | R01 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) |
| PAR-21-315 | June 21, 2024 | UG3/UH3 | Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) |
| PAR-21-305 | January 10, 2025 | R01 | Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
| PAR-21-282 | June 21, 2024 | U44 | Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) |
| PAR-21-248 | May 8, 2024 | R01 | Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) |
| PAR-21-229 | May 8, 2025 | R01 | Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) |
| PAR-21-163 | May 8, 2024 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
| PAR-21-155 | May 8, 2024 | R15 | Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
| PAR-21-154 | May 8, 2024 | R15 | Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) |
| PAR-21-115 | January 8, 2025 | R01 | Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
| PA-24-195 | May 8, 2027 | K99/R00 | NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) |
| PA-24-194 | May 8, 2027 | K99/R00 | NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) |
BACK TO TOP